BIOHK2022: Hong Kong needs a more integrated and harmonised ecosystem to become a biotech fundraising hub, panellists say

December 15, 2022 Chin@Strategy

From left, Bin Li of Lake Bleu Capital, Vijay Karwal of AffaMed Therapeutics, Donald Lung, CFO of Antengene and Yinxiang Wang, chairman and CEO of Jacobio Pharma, take part in a panel discussion on ‘Capital Market for Healthcare Post Pandemic’ at BIOHK2022 on Thursday. Photo: Handout

South China Morning Post

Related posts

• 

  October 17, 2025 Media Library 0

  Alibaba Cloud claims to slash Nvidia GPU use by 82% with new pooling system

  Alibaba Group Holding has introduced a computing pooling solution that it said led to an 82...

• 

  October 17, 2025 Media Library 0

  Chinese spy drama Silent Honour inspires praise for real-life agents

  The Chinese public has come out in force to pay tribute to Communist Party undercover agents...

• 

  October 17, 2025 Media Library 0

  New lending and repo plans accelerate the yuan’s challenge to the US dollar

  When Hong Kong businessman Sunny Yip Yuk-chik heard about a new scheme that would make it...